New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Inhibrx Biosciences, Inc. (INBX) vs Jade Biosciences, Inc. (JBIO)
- Inhibrx Biosciences, Inc. INBX 68.97 −7.21%
- Jade Biosciences, Inc. JBIO 15.31 +1.66%
Inhibrx Biosciences, Inc. and Jade Biosciences, Inc. are both Biotechnology companies. Inhibrx Biosciences, Inc. and Jade Biosciences, Inc. are of similar size ($1.1B and $1.0B). Across the 8 metrics below, Inhibrx Biosciences, Inc. leads on 4 and Jade Biosciences, Inc. on 4.
Valuation
Profitability
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack